***Background.*** There has been a substantial increase in infant pertussis cases over the past decade. Immunization is the primary method of pertussis prevention. Recommendations for pertussis vaccine (Tdap) have expanded to include a dose of Tdap for all adults, with particular attention to pregnant women in the 3^rd^ trimester of each pregnancy and contacts of infants less than 1 year of age.

***Methods.*** We surveyed adults with children 3 years of age or younger accessing services provided by Upstate Medical University in Syracuse, New York to determine community awareness of pertussis infection and Tdap receipt. We then surveyed obstetric (OB) and pediatric providers across New York State to determine provider attitudes regarding Tdap.

***Results.*** 502 adults (86% female) were surveyed. 344 (69%) and 118 (24%) correctly identified pertussis symptoms and the population at high-risk for developing complications from infection, respectively. 401 (80%) adults stated that they have heard of the pertussis vaccine. 211 (42%) and 299 (60%) adults stated their doctor or child\'s pediatrician have discussed Tdap with them, respectively. Only 181(36%) participants stated that they have received Tdap in the past 5 years. Tdap receipt was strongly associated with a provider recommendation (p \< 0.05). A total of 123 OB and 438 pediatric providers responded to the surveys. OB providers (14/123, 11%) were more likely than pediatric providers (5/438, 1%) to express concerns with Tdap safety (p \< 0.05). 12% of both OB and pediatric providers expressed concerns regarding Tdap efficacy. While 113/123 (92%) of the OB providers knew that Tdap is recommended with each pregnancy, only 99 (80%) recommended Tdap to eligible pregnant patients, and only 80 (65%) administered Tdap in their practice. 174/438 (40%) pediatric providers state they never discuss parental vaccine status at patient visits and 64/123 (52%) of OB providers state they never discuss pediatric vaccines with their pregnant patients.

***Conclusion.*** Patient and provider hesitancy regarding Tdap vaccine continues. Hesitancy among obstetrical providers is particularly common. Interventions that improve both provider and patient attitudes regarding pertussis infection and vaccine will likely improve Tdap vaccination rates.
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